MeiraGTx (MGTX)
Develops locally delivered AAV gene therapies and manufactures its own viral vectors.
$11.97
vs last close−0.38 (−3.04%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 82.30% | 79.04M shares | |
|---|---|---|---|
| 162 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 2.03% | 1.95M shares | |
| 5 holders · as of Jul 21, 2026 | |||
| Other | ≈ 15.67% | 15.05M shares | |
| remainder | |||
96.04M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
162 holders · 79.04M shares · 39 new positions · 119 increased · 23 reduced · 13 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Sanofi | 12.20M | 12.70% | 0 | Jul 28, 2026 |
| Perceptive Advisors LLC | 10.79M | 11.23% | +460.6K | Aug 14, 2026 |
| Rubric Capital Management LP | 9.10M | 9.47% | +2.10M | Aug 14, 2026 |
| Johnson & Johnson | 6.64M | 6.91% | 0 | Aug 6, 2026 |
| BlackRock, Inc. | 4.76M | 4.95% | +1.59M | Aug 7, 2026 |
| Adage Capital Partners GP, L.L.C. | 4.40M | 4.58% | +400.0K | Aug 14, 2026 |
| Opaleye Management Inc. | 3.55M | 3.70% | +1.43M | Aug 14, 2026 |
| Millennium Management LLC | 2.97M | 3.09% | −493.9K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Perceptive Advisors LLCincl. Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd. | 12.60% | 11.74M | 13D | Apr 24, 2026 |
| Rubric Capital Management LP | 7.90% | 6.18M | 13G | Feb 13, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 18, 2026 | Alexandria Forbesdirector, officer: PRESIDENT & CEO | Sale | 62,000 | $13.86 | 1,325,695 |
| Jul 21, 2026 | Richard Girouxofficer: CFO & COO | Sale | 56,000 | $12.51 | 908,530 |
| Jul 7, 2026 | Stuart Naylorofficer: CHIEF SCI OFCR, OPHTHALMOLOGY | Sale · 2 lots | 27,659 | $14.80 | 640,846 |
| May 19, 2026 | Alexandria Forbesdirector, officer: PRESIDENT & CEO | Sale | 62,000 | $9.17 | 1,387,695 |
| Apr 21, 2026 | Richard Girouxofficer: CFO & COO | Sale | 56,000 | $10.22 | 971,530 |
| Apr 7, 2026 | Stuart Naylorofficer: CHIEF DEV. OFFICER | Sale | 27,661 | $9.36 | 668,505 |
| Mar 24, 2026 | Alexandria Forbesdirector, officer: PRESIDENT & CEO | Sale | 62,000 | $7.41 | 1,449,695 |
| Oct 21, 2025 | Richard Girouxofficer: CFO & COO | Sale | 24,000 | $8.87 | 829,494 |
| Oct 7, 2025 | Alexandria Forbesdirector, officer: PRESIDENT & CEO | Sale | 47,500 | $8.39 | 1,313,983 |
House and Senate disclosures
Not reported.